Loading companies…
Loading companies…
China · Biotech · Healthtech · Enterprise software
Develops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseases
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | Undisclosed | Blue Ocean Capital — Role not disclosedLotus Lake Ventures — Role not disclosedMr. Yousheng Shen — Role not disclosedStars Capital — Role not disclosedTainuo Capital — Role not disclosed |